1st Quarter - Termination Amendment

BELL HEROUX, LLC for SICKLE CELL DISEASE ASSOCIATION OF AMERICA, INC

Firm
Client
Income
$20,000
Expenses
—
Terminated
Mar 30, 2012

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 24, 2012 $20,000 Replaced
1st Quarter - Termination Amendment (this page) Jan 22, 2013 $20,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to reauthorization of the Sickle Cell Disease Treatment Act, the New Born Screening Program and other matters related to the treatement and research for the cure to Sickle Cell Disease

LobbyistCovered position, as disclosed
STEPHAN DMITRI BELL Leg Director, Rep. Earl Hilliard
JON PAUL HEROUX Chief Counsel, Merit Systems Protection Board

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Matters related to the FY 2013 budget and appopriations bills for programs within HRSA, CMS, NIH, and other agencies for the treatment and cure of Sickle Cell Disease.

LobbyistCovered position, as disclosed
STEPHAN DMITRI BELL Leg. Dir., Rep. Earl Hilliard
JON PAUL HEROUX Chief Counsel, US Merit Systems Protection Board

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.